UK markets closed

Zealand Pharma A/S (0NZU.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
165.50+4.40 (+2.73%)
At close: 05:22PM BST
Full screen
Previous close161.10
Open164.50
Bid0.00 x 0
Ask0.00 x 0
Day's range161.00 - 165.90
52-week range70.05 - 212.60
Volume51,489
Avg. volume37,369
Market cap7.581B
Beta (5Y monthly)1.05
PE ratio (TTM)N/A
EPS (TTM)-23.13
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 million

    Company announcement – No. 44 / 2022 Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 million NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE

  • Globe Newswire

    Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares

    Company announcement – No. 43 / 2022 Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION EXCEPT P

  • Globe Newswire

    Total number of shares and voting rights in Zealand Pharma at September 30, 2022

    Company announcement – No. 42 / 2022 Total number of shares and voting rights in Zealand Pharma at September 30, 2022 Copenhagen, DK and Boston, MA, September 30, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at th